{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:43:33Z","timestamp":1740141813144,"version":"3.37.3"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"National Antilles Foundation for Clinical Higher Education"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background and Hypothesis<\/jats:title>\n                  <jats:p>There is a substantial gap in life expectancy between patients with severe mental illness (SMI) and the general population and it is important to understand which factors contribute to this difference. Research suggests an association between tardive dyskinesia (TD) and mortality; however, results are inconclusive. In addition, studies investigating associations between parkinsonism or akathisia and mortality are rare. We hypothesized that TD would be a risk factor for mortality in patients with SMI.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Study Design<\/jats:title>\n                  <jats:p>We studied a cohort of 157 patients diagnosed predominantly with schizophrenia on the former Netherlands Antilles. TD, parkinsonism, and akathisia were assessed with rating scales on eight occasions over a period of 18 years. Twenty-four years after baseline, survival status and if applicable date of death were determined. Associations between movement disorders and survival were analyzed using Cox regression. Sex, age, antipsychotics, antidepressants and benzodiazepines at each measurement occasion were tested as covariates.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Study Results<\/jats:title>\n                  <jats:p>Parkinsonism was a significant risk factor with an HR of 1.02 per point on the motor subscale of the Unified Parkinson\u2019s Disease Rating Scale (range 0\u201356). TD and akathisia were not significantly associated with mortality.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Parkinsonism may be an important risk factor for mortality in SMI patients. This finding calls for more follow-up and intervention studies to confirm this finding and to explore whether treatment or prevention of parkinsonism can reduce excess mortality.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/schbul\/sbac037","type":"journal-article","created":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T12:14:25Z","timestamp":1648210465000},"page":"766-773","source":"Crossref","is-referenced-by-count":2,"title":["Movement Disorders and Mortality in Severely Mentally Ill Patients: The Curacao Extrapyramidal Syndromes Study XIV"],"prefix":"10.1093","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2189-4475","authenticated-orcid":false,"given":"Anne E","family":"Willems","sequence":"first","affiliation":[{"name":"Research Department, Psychiatric Centre GGz Centraal , Amersfoort, The Netherlands"},{"name":"School for Mental Health and NeuroScience (MHeNS), Maastricht University , Maastricht , The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte L","family":"Mentzel","sequence":"additional","affiliation":[{"name":"Research Department, Psychiatric Centre GGz Centraal , Amersfoort, The Netherlands"},{"name":"School for Mental Health and NeuroScience (MHeNS), Maastricht University , Maastricht , The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter Roberto","family":"Bakker","sequence":"additional","affiliation":[{"name":"Arkin, Institute for Mental Health , Amerstdam , The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim","family":"Van Os","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Brain Centre Rudolf Magnus, University Medical Centre Utrecht , Utrecht , The Netherlands"},{"name":"King\u2019s College London, King\u2019s Health Partners, Department of Psychosis Studies, Institute of Psychiatry , London , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diederik E","family":"Tenback","sequence":"additional","affiliation":[{"name":"Veldzicht Centre for Transcultural Psychiatry, Custodial Institutions Agency (DJI), Ministry of Justice and Security , Balkbrug , The Netherlands"},{"name":"FPC de Oostvaarderskliniek, Custodial Institutions Agency (DJI), Ministry of Justice and Security , Almere , The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Gelan","sequence":"additional","affiliation":[{"name":"Capriles Psychiatric Clinic, GGz Cura\u00e7ao , Groot Kwartier, Cura\u00e7ao"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erna","family":"Daantjes","sequence":"additional","affiliation":[{"name":"Capriles Psychiatric Clinic, GGz Cura\u00e7ao , Groot Kwartier, Cura\u00e7ao"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn E","family":"Matroos","sequence":"additional","affiliation":[{"name":"Capriles Psychiatric Clinic, GGz Cura\u00e7ao , Groot Kwartier, Cura\u00e7ao"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans W","family":"Hoek","sequence":"additional","affiliation":[{"name":"Parnassia Psychiatric Institute , The Hague , The Netherlands"},{"name":"Department of Psychiatry, University Medical Centre Groningen, University of Groningen , Groningen , The Netherlands"},{"name":"Department of Epidemiology, Columbia University, Mailman School of Public Health , New York, New York , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter N","family":"Van Harten","sequence":"additional","affiliation":[{"name":"Research Department, Psychiatric Centre GGz Centraal , Amersfoort, The Netherlands"},{"name":"School for Mental Health and NeuroScience (MHeNS), Maastricht University , Maastricht , The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,4,29]]},"reference":[{"key":"2022062117232199800_CIT0001","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12888-014-0261-4","article-title":"Impact of socioeconomic deprivation on rate and cause of death in severe mental illness","volume":"14","author":"Martin","year":"2014","journal-title":"BMC Psychiatry."},{"key":"2022062117232199800_CIT0002","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-244X-10-77","article-title":"All-cause mortality among people with serious mental illness (SMI), substance use disorders, and depressive disorders in southeast London: a cohort study","volume":"10","author":"Chang","year":"2010","journal-title":"BMC Psychiatry."},{"issue":"1\u20133","key":"2022062117232199800_CIT0003","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.schres.2011.06.008","article-title":"Life expectancy among persons with schizophrenia or bipolar affective disorder","volume":"131","author":"Laursen","year":"2011","journal-title":"Schizophr Res."},{"issue":"10","key":"2022062117232199800_CIT0004","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1001\/archpsyc.64.10.1123","article-title":"A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?","volume":"64","author":"Saha","year":"2007","journal-title":"Arch Gen Psychiatry."},{"issue":"1","key":"2022062117232199800_CIT0005","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40345-018-0140-x","article-title":"Mortality rate trends in patients diagnosed with schizophrenia or bipolar disorder: a nationwide study with 20 years of follow-up","volume":"7","author":"Lomholt","year":"2019","journal-title":"Int J Bipolar Disord."},{"issue":"3","key":"2022062117232199800_CIT0006","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1176\/appi.ajp.2012.12050599","article-title":"Comorbidities and mortality in persons with schizophrenia: a Swedish National Cohort Study","volume":"170","author":"Crump","year":"2013","journal-title":"Am J Psychiatry."},{"issue":"9690","key":"2022062117232199800_CIT0007","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(09)60742-X","article-title":"11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)","volume":"374","author":"Tiihonen","year":"2009","journal-title":"Lancet."},{"issue":"9","key":"2022062117232199800_CIT0008","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/jamapsychiatry.2013.1394","article-title":"Comorbidities and mortality in bipolar disorder: a swedish national cohort study","volume":"70","author":"Crump","year":"2013","journal-title":"JAMA Psychiatry."},{"issue":"1","key":"2022062117232199800_CIT0009","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12991-017-0134-6","article-title":"Lifestyle factors and the metabolic syndrome in Schizophrenia: a cross-sectional study","volume":"16","author":"Heald","year":"2017","journal-title":"Ann General Psychiatry."},{"key":"2022062117232199800_CIT0010","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/j.2051-5545.2011.tb00014.x","article-title":"Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care","volume":"10","author":"De Hert","year":"2011","journal-title":"World Psychiatry ."},{"issue":"2","key":"2022062117232199800_CIT0011","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/00004714-200004000-00011","article-title":"Tardive dyskinesia associated with higher mortality in psychiatric patients: results of a meta-analysis of seven independent studies","volume":"20","author":"Ballesteros","year":"2000","journal-title":"J Clin Psychopharmacol."},{"issue":"1","key":"2022062117232199800_CIT0012","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/JCP.0b013e3181929f94","article-title":"Mortality rates among patients with schizophrenia and tardive dyskinesia","volume":"29","author":"Chong","year":"2009","journal-title":"J Clin Psychopharmacol."},{"issue":"10","key":"2022062117232199800_CIT0013","doi-asserted-by":"crossref","first-page":"e25588","DOI":"10.1371\/journal.pone.0025588","article-title":"Long-stay psychiatric patients: a prospective study revealing persistent antipsychotic-induced movement disorder","volume":"6","author":"Bakker","year":"2011","journal-title":"PLoS One."},{"key":"2022062117232199800_CIT0014","article-title":"An epidemiological approach to elucidate dopaminergic mechanisms in tardive dyskinesia in schizophrenia","author":"Tenback","year":"2006","journal-title":"University Press Maastricht"},{"issue":"3","key":"2022062117232199800_CIT0015","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1176\/ajp.135.3.371","article-title":"Mortality of patients with tardive dyskinesia","volume":"135","author":"Mehta","year":"1978","journal-title":"Am J Psychiatry."},{"key":"2022062117232199800_CIT0016","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1192\/bjp.148.3.310","article-title":"Mortality and facial dyskinesia","volume":"148","author":"McClelland","year":"1986","journal-title":"Br J Psychiatry."},{"issue":"1","key":"2022062117232199800_CIT0017","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2302\/kjm.38.70","article-title":"Mortality rate of schizophrenic patients with tardive dyskinesia during 10 years: a controlled study","volume":"38","author":"Yagi","year":"1989","journal-title":"Keio J Med."},{"issue":"9","key":"2022062117232199800_CIT0018","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1176\/ajp.136.9.1228-a","article-title":"Mortality and tardive dyskinesia","volume":"136","author":"Kucharski","year":"1979","journal-title":"Am J Psychiatry."},{"issue":"8","key":"2022062117232199800_CIT0019","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1176\/ajp.141.8.1018b","article-title":"Mortality rate in tardive dyskinesia","volume":"141","author":"Yassa","year":"1984","journal-title":"Am J Psychiatry."},{"issue":"4","key":"2022062117232199800_CIT0020","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1192\/bjp.bp.108.049395","article-title":"Mortality and tardive dyskinesia: long-term study using the US National Death Index","volume":"194","author":"Dean","year":"2009","journal-title":"Br J Psychiatry."},{"issue":"02","key":"2022062117232199800_CIT0021","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/s-0028-1102911","article-title":"Relationship between neuroleptic extrapyramidal syndromes and patients\u2019 all-cause mortality","volume":"42","author":"Modestin","year":"2009","journal-title":"Pharmacopsychiatry."},{"key":"2022062117232199800_CIT0022","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0920-9964(95)00096-8","article-title":"The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia. The Cura\u00e7ao Extrapyramidal Syndromes Study: I","volume":"19","author":"van Harten","year":"1996","journal-title":"Schizophr Res."},{"issue":"2\u20133","key":"2022062117232199800_CIT0023","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0920-9964(97)00058-3","article-title":"The inter-relationships of tardive dyskinesia, parkinsonism, akathisia and tardive dystonia: the Cura\u00e7ao Extrapyramidal Syndromes Study II","volume":"26","author":"van Harten","year":"1997","journal-title":"Schizophr Res."},{"key":"2022062117232199800_CIT0024","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.4088\/JCP.v67n1212","article-title":"Incidence of tardive dyskinesia and tardive dystonia in African Caribbean Patients on long-term antipsychotic treatment: the Cura\u00e7ao Extrapyramidal Syndromes Study V","volume":"67","author":"van Harten","year":"2006","journal-title":"J Clin Psychiatry."},{"issue":"2","key":"2022062117232199800_CIT0025","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.euroneuro.2007.07.004","article-title":"Evidence that lithium protects against tardive dyskinesia: the Cura\u00e7ao Extrapyramidal Syndromes study VI","volume":"18","author":"van Harten","year":"2008","journal-title":"Eur Neuropsychopharmacol."},{"issue":"1\u20133","key":"2022062117232199800_CIT0026","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.schres.2007.09.010","article-title":"The course of tardive dystonia in Afro Caribbean patients, a population-based study: the Curacao extrapyramidal syndromes study: VII","volume":"98","author":"van Harten","year":"2008","journal-title":"Schizophr Res"},{"issue":"6","key":"2022062117232199800_CIT0027","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00005053-198506000-00005","article-title":"Assessment of tardive dyskinesia using the Abnormal Involuntary Movement Scale","volume":"173","author":"Lane","year":"1985","journal-title":"J Nerv Ment Dis."},{"key":"2022062117232199800_CIT0028","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archpsyc.1982.04290040080014","article-title":"Research diagnosis for tardive dyskinesia","volume":"39","author":"Schooler","year":"1982","journal-title":"Arch Gen Psychiatry."},{"key":"2022062117232199800_CIT0029","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/mds.870090112","article-title":"Unified Parkinson disease rating scale characteristics and structure","volume":"9","author":"Mart\u00ednez-Mart\u00edn","year":"1994","journal-title":"Mov Disord."},{"key":"2022062117232199800_CIT0030","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"Br J Psychiatry."},{"year":"2021","author":"World Health Organization (WHO) Collaborating Centre for Drug Statistics Methodology","key":"2022062117232199800_CIT0031"},{"key":"2022062117232199800_CIT0032","volume-title":"An Introduction to Survival Analysis using Stata","author":"Cleves","year":"2010","edition":"3"},{"issue":"1\u20133","key":"2022062117232199800_CIT0033","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.schres.2007.10.018","article-title":"Evolution of neuroleptic-induced extrapyramidal syndromes under long-term neuroleptic treatment","volume":"100","author":"Modestin","year":"2008","journal-title":"Schizophr Res."},{"issue":"1","key":"2022062117232199800_CIT0034","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00406-013-0436-x","article-title":"Physical comorbidity and its relevance on mortality in schizophrenia: a naturalistic 12-year follow-up in general hospital admissions","volume":"264","author":"Schoepf","year":"2014","journal-title":"Eur Arch Psychiatry Clin Neurosci."},{"issue":"1","key":"2022062117232199800_CIT0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/0891988717743589","article-title":"Predictors of mortality in nondemented patients with Parkinson disease: motor symptoms versus nonmotor symptoms","volume":"31","author":"Santos-Garc\u00eda","year":"2018","journal-title":"J Geriatr Psychiatry Neurol."},{"key":"2022062117232199800_CIT0036","first-page":"1270","article-title":"What predicts mortality in Parkinson disease? A prospective population-based long-term study","volume-title":"Neurology","author":"Forsaa","year":"2010"},{"issue":"4","key":"2022062117232199800_CIT0037","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00455-017-9802-6","article-title":"Swallowing Disorders in Schizophrenia","volume":"32","author":"Kulkarni","year":"2017","journal-title":"Dysphagia"},{"issue":"5","key":"2022062117232199800_CIT0038","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/schbul\/sbt125","article-title":"Spontaneous Parkinsonism is associated with cognitive impairment in antipsychotic-naive patients with first-episode psychosis: a 6-month follow-up study","volume":"40","author":"Cuesta","year":"2014","journal-title":"Schizophr Bull."},{"issue":"6","key":"2022062117232199800_CIT0039","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/schbul\/sbw023","article-title":"Prediction of neurocognitive deficits by Parkinsonian motor impairment in schizophrenia: a study in neuroleptic-na\u00efve subjects, unaffected first-degree relatives and healthy controls from an indigenous population","volume":"42","author":"Molina","year":"2016","journal-title":"Schizophr Bull."},{"issue":"2","key":"2022062117232199800_CIT0040","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00406-014-0511-y","article-title":"Antipsychotic-induced parkinsonism is associated with working memory deficits in schizophrenia-spectrum disorders","volume":"265","author":"Potvin","year":"2015","journal-title":"Eur Arch Psychiatry Clin Neurosci."},{"issue":"4","key":"2022062117232199800_CIT0041","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/schbul\/sbab028","article-title":"Exploring the relationship between movement disorders and physical activity in patients with schizophrenia: an actigraphy study","volume":"47","author":"Pieters","year":"2021","journal-title":"Schizophr Bull."},{"issue":"1","key":"2022062117232199800_CIT0042","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1600-0447.1987.tb02754.x","article-title":"Morbidity and mortality in tardive dyskinesia: associations in chronic schizophrenia","volume":"75","author":"Youssef","year":"1987","journal-title":"Acta Psychiatr Scand."},{"issue":"4","key":"2022062117232199800_CIT0043","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/hup.470070404","article-title":"The life expectancy of schizophrenic patients with tardive dyskinesia","volume":"7","author":"Inada","year":"1992","journal-title":"Hum Psychopharmacol Clin Exp."},{"issue":"5","key":"2022062117232199800_CIT0044","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.comppsych.2007.05.003","article-title":"Worsening of psychosis in schizophrenia is longitudinally associated with tardive dyskinesia in the European Schizophrenia Outpatient Health Outcomes study","volume":"48","author":"Tenback","year":"2007","journal-title":"Compr Psychiatry."},{"key":"2022062117232199800_CIT0045","doi-asserted-by":"crossref","first-page":"2s","DOI":"10.1097\/00004714-199804001-00002","article-title":"Predictors of outcome in schizophrenia","volume":"18","author":"Murray","year":"1998","journal-title":"Journal of clinical psychopharmacology"},{"issue":"13","key":"2022062117232199800_CIT0046","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1017\/S0033291717000873","article-title":"Antipsychotic medication and long-term mortality risk in patients with schizophrenia; a systematic review and meta-analysis","volume":"47","author":"Vermeulen","year":"2017","journal-title":"Psychol Med."},{"issue":"3","key":"2022062117232199800_CIT0047","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/schbul\/sbu164","article-title":"Antipsychotic treatment and mortality in schizophrenia","volume":"41","author":"Torniainen","year":"2014","journal-title":"Schizophr Bull."},{"issue":"1","key":"2022062117232199800_CIT0048","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/wps.20699","article-title":"20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20)","volume":"19","author":"Taipale","year":"2020","journal-title":"World Psychiatry."},{"issue":"6","key":"2022062117232199800_CIT0049","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1176\/appi.ajp.2015.15050618","article-title":"Mortality and cumulative exposure to antipsychotics, antidepressants, and benzodiazepines in patients with schizophrenia: an observational follow-up study","volume":"173","author":"Tiihonen","year":"2016","journal-title":"Am J Psychiatry."},{"issue":"3277","key":"2022062117232199800_CIT0050","doi-asserted-by":"crossref","first-page":"708361","DOI":"10.3389\/fpsyg.2021.708361","article-title":"Cognition-mortality associations are more pronounced when estimated jointly in longitudinal and time-to-event models","volume":"12","author":"Aichele","year":"2021","journal-title":"Front Psychol."},{"issue":"3","key":"2022062117232199800_CIT0051","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2174\/1874473711205030243","article-title":"Substance abuse and movement disorders: complex interactions and comorbidities","volume":"5","author":"Deik","year":"2012","journal-title":"Curr Drug Abuse Rev."},{"issue":"6","key":"2022062117232199800_CIT0052","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/0006-3223(90)90483-I","article-title":"Cigarette smoking and neuroleptic-induced parkinsonism","volume":"28","author":"Decina","year":"1990","journal-title":"Biol Psychiatry."}],"container-title":["Schizophrenia Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article-pdf\/48\/4\/766\/44157243\/sbac037.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article-pdf\/48\/4\/766\/44157243\/sbac037.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T17:26:39Z","timestamp":1655832399000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article\/48\/4\/766\/6576125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,29]]},"references-count":52,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4,29]]},"published-print":{"date-parts":[[2022,6,21]]}},"URL":"https:\/\/doi.org\/10.1093\/schbul\/sbac037","relation":{},"ISSN":["0586-7614","1745-1701"],"issn-type":[{"type":"print","value":"0586-7614"},{"type":"electronic","value":"1745-1701"}],"subject":[],"published-other":{"date-parts":[[2022,7,1]]},"published":{"date-parts":[[2022,4,29]]}}}